These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9089665)

  • 1. The effects of a 5-HT1A receptor agonist and antagonist on the 5-hydroxytryptamine release in the central nucleus of the amygdala: a microdialysis study with flesinoxan and WAY 100635.
    Bosker F; Vrinten D; Klompmakers A; Westenberg H
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):347-53. PubMed ID: 9089665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
    Bosker FJ; de Winter TY; Klompmakers AA; Westenberg HG
    J Neurochem; 1996 Jun; 66(6):2546-55. PubMed ID: 8632181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe.
    Bosker FJ; Klompmakers A; Westenberg HG
    Eur J Pharmacol; 1997 Aug; 333(2-3):147-57. PubMed ID: 9314028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat.
    Adell A; Artigas F
    Br J Pharmacol; 1998 Nov; 125(6):1361-7. PubMed ID: 9863668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex.
    Casanovas JM; Hervás I; Artigas F
    Neuroreport; 1999 May; 10(7):1441-5. PubMed ID: 10380960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release.
    Casanovas JM; Berton O; Celada P; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):248-54. PubMed ID: 10997727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: increase in Na+, K(+)-ATPase activity in renal proximal tubules via activation of 5-HT1A receptors.
    Soares-da-Silva P; Pinto-do-O PC; Bertorello AM
    Br J Pharmacol; 1996 Mar; 117(6):1199-203. PubMed ID: 8882616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala.
    Bosker FJ; Cremers TI; Jongsma ME; Westerink BH; Wikström HV; den Boer JA
    J Neurochem; 2001 Mar; 76(6):1645-53. PubMed ID: 11259482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
    Casanovas JM; Lésourd M; Artigas F
    Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties.
    Assié MB; Koek W
    Eur J Pharmacol; 1996 May; 304(1-3):15-21. PubMed ID: 8813579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors.
    Calcagno E; Carli M; Invernizzi RW
    J Neurochem; 2006 Feb; 96(3):853-60. PubMed ID: 16405507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT and 5-HT1A receptor agonists and antagonists on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.
    Wang Y; Jones JF; Ramage AG; Jordan D
    Br J Pharmacol; 1995 Oct; 116(4):2291-7. PubMed ID: 8564262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.